Skip to main content
Premium Trial:

Request an Annual Quote

Affy s SARS Array Freely Available to Researchers via NIAID/TIGR Program

NEW YORK, June 23 - Affymetrix said today that its SARS coronavirus microarrays would be provided at no cost to qualifying researchers through the Pathogen Functional Genomics Resource Center, which is operated by the Institute for Genomic Research under a contract with the National Institute for Allergy and Infectious Diseases.


The Affymetrix SARS array resequences the entire 29,700 base pairs in the SARS virus and was designed using sequence from public health centers in Canada, Asia, and the United States.


According to Affymetrix, researchers are expected to use the new array to categorize different isolates of the virus into subtypes or strains, compare patient outcomes among different pathogen subtypes, and study how the virus is evolving over time.


Any researcher, regardless of affiliation, can apply for the arrays and other reagents using an application available here.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.